Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Nov 6;18(11):e0293822. doi: 10.1371/journal.pone.0293822

Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study

Ibrahim A Naqid 1,*, Ahmed A Mosa 1, Shah Vahel Ibrahim 1, Nizar Hussein Ibrahim 1, Nawfal R Hussein 1
Editor: Mohamed Lounis2
PMCID: PMC10627443  PMID: 37930973

Abstract

Background and aims

Healthcare staff are at high risk of occupational exposure to Hepatitis B and other blood-borne diseases. Lack of education about the knowledge of Hepatitis B virus contributes to an increase in cases. This study aims to determine the knowledge of the Hepatitis B virus among the medical professionals in Duhok province, Kurdistan Region of Iraq, and to determine their knowledge of the importance of vaccination.

Materials and methods

This cross-sectional study was conducted in Duhok province, Kurdistan Region of Iraq, among medical science students from November 2022 to February 2023 and a total of 511 students participated in the study. A Self-administered questionnaire comprising 22 items categorized into five sections was distributed to the students either electronically or by paper and pen method. The survey utilized a Five-point Likert scale when assessing respondents’ opinions on knowledge, attitude, and practice (KAP). Microsoft Excel and GraphPad Prism 9 were used for statistical analysis.

Results

A total of 511 responses were collected from medical, dental, pharmacy, and laboratory students. The average age of the participants was 20.74 ±1.43 years. Among the respondents, only 96 (18.8%) were fully vaccinated against the Hepatitis B virus (received 3 or more doses of the vaccine), while 294 (57.5%) were not vaccinated. Lack of vaccination programs was the major reason for not receiving a vaccination (n = 182, 62%). About 286 (55.96%) of the participants had good knowledge, attitude, and practice on Hepatitis B, manifesting median scores of 26, 18, and 20, respectively.

Conclusion

In our study, half of the students were found to be unvaccinated, mainly due to the absence of vaccination programs. Vaccinated students exhibited better knowledge, attitude, and practice toward the infection than non-vaccinated students. Therefore, we recommend the implementation of a vaccination program as well as training on infection prevention guidelines to increase awareness and encourage vaccination.

Introduction

Hepatitis B virus (HBV) infection has been identified as the most common viral infection worldwide. Nearly two billion people have been infected with it, and nearly half a billion people are chronic virus carriers [1]. The 2019 Global Burden of Disease study documented 555,000 deaths worldwide attributable to diseases related to the Hepatitis B virus (HBV), and it reported a decline in the prevalence of HBV [2]. The route of transmission of HBV is through contact with infected blood or semen. There are three major modes of transmission: (1) transmission from infected mothers to neonates prenatally, (2) sexual transmission, and (3) unsafe injections, dialysis, and blood transfusions. Screening of blood donors for HBsAg has been a vital precaution in reducing the prevalence of the Hepatitis B virus [3].

Hepatitis B vaccines have been available in the United States since 1981 [4]. It is reported that with the increase of age, the antibody response declines. Immunization during childhood or adolescence offers the most potent protection against the virus. [5]. Infection with the Hepatitis B virus has been associated with predisposing patients to develop liver diseases such as liver cirrhosis, liver failure, and hepatocellular carcinoma. The Hepatitis B vaccine has been effective in the prevention of hepatocellular carcinoma [6].

Healthcare staffs are at high risk of occupational exposure to Hepatitis B, Hepatitis C, and other blood-borne diseases. In developing countries, the poor emphasis on awareness and knowledge of blood-borne diseases puts the population at higher risk [7]. In 2017, a study in Duhok, Iraq, focused on and interpreted the knowledge of Hepatitis B among healthy volunteers. In that study, it was reported that more than 40% of the participants did not know that the vaccine was available in Duhok City, and it was suggested that more awareness should be promoted in the region [8].

In 2016, a study was conducted in Duhok, Kurdistan Region, Iraq, to view the prevalence of Hepatitis B and C viruses among blood donors in the region [9]. According to the study, it was stated that none of the donors obtained vaccination against HBV due to the initiation of vaccination programs began in 2003, which meant that only people younger than 12 years old were vaccinated. Secondly, the unavailability was a serious barrier for not inoculation in the region. Lastly, the lack of awareness of the vaccine had a huge role in poor vaccination status among the donors. Lack of education about the knowledge of Hepatitis B virus aids in increasing the disease. There are also high-risk factors in Duhok City, including drug users sharing contaminated needles, sexual encounters with infected people, and healthcare staff [10, 11].

Aims of the study

Our study aims to determine the knowledge, attitude and practice (KAP) towards the Hepatitis B virus among the medical science students in Duhok, Kurdistan Region of Iraq. Additionally, the study aims to determine the vaccination status of these students, exploring the underlying reasons for those who have not been vaccinated. This will help in encouraging awareness and educating medical sciences staff in particular and the population in general to protect themselves from the virus, and advocate for the effective role of the vaccine against the disease initiation and progression.

Materials and methods

Study design

This cross-sectional study was carried out among medical science students in Duhok province, Kurdistan Region of Iraq. The data were collected from November 2022 to February 2023, and a total of 511 students were recruited for the study. A self-administered questionnaire was delivered to students electronically using both the Google Forms platform and the paper and pen method. The research was conceptualized and conducted according to the Standards for Strengthening the Reporting of Observational Studies in Epidemiology.

Study tools

The study survey was derived from a previously validated questionnaire with certain adjustments made by the researchers to meet the current study aims [12]. The questionnaire comprised 22 items which were categorized into five sections. The first section included three questions related to the basic demographic characteristics of participants like age, gender, and college. The second section featured three items regarding the vaccination status, Hepatitis B vaccine doses, and the reason for not being vaccinated.

The last part consisted of questions designed to examine students’ knowledge, attitude, and practice on Hepatitis B, which may be useful in understanding students’ acceptance and reticence regarding the Hepatitis B vaccine. This part of the questionnaire was assorted into three sections: six items to test participants’ Hepatitis B knowledge, five items to assess participants’ attitudes regarding the virus, and the final five questions to address students’ practice.

Responses to the questions about knowledge, attitude, and practice were measured using a Five-point Likert scale, ranging from 1–5 from strongly disagree to strongly agree. However, one question in the knowledge section (i.e., Hepatitis B can be transmitted by shaking hands, coughing/sneezing, and contaminated food/water) and two questions in the attitude section (I feel uncomfortable sitting with a Hepatitis B infected person, and I don’t need Hepatitis B vaccination because I am not at risk) were reversed scored. Knowledge of Hepatitis B was examined by adding six questions with a potential score ranging from 6–30. The Attitude and Practice sections were assessed by adding five questions with a possible score ranging from 5–25. A possible KAP score can vary between 16 and 80. Participants with a score at or above the median were categorized as having a favorable KAP score, while those with a score below the median were classified as having an inadequate KAP score [12].

Inclusion/Exclusion criteria

The inclusion criteria were participants of more than 18 years of age, students in one of the medical sciences colleges in Duhok province, and consenting to be recruited in the study. At the same time, non-medical science students from other provinces, as well as data with incomplete information, were excluded from the study.

Statistical analysis

Statistical analysis was performed using Microsoft Excel and GraphPad Prism 9 software. Frequencies and percentages were used to describe descriptive statistics of the participants. The association between basic-demographic characteristics variables and KAP score was assessed by using Chi-Square, or Fisher’s exact test. Statistical significance was defined as a p-value of 0.05 or less.

Results

Basic demographic characteristics

The basic demographic characteristics of the respondents who participated in this study are shown in Table 1. The mean age of the participants was 20.74 (±1.43 SD) years. Two hundred seventy-one respondents were female (53%). The majority of the respondents were medical students (n = 248, 48.5%) followed by dental students (n = 161, 31.5%). Regarding the vaccination status, 217 (42.5%) of the students were vaccinated while 294 (57.5%) were not vaccinated. Among the vaccinated students, 96 (44.2%) were fully vaccinated (received 3 or more doses of the vaccine). The lack of a vaccination program was the major reason for not being vaccinated (n = 182, 62%).

Table 1. Demographic characteristics and Hepatitis B vaccination status of the participants.

Variables n (%)
Age
 20 and below 243 (47.6)
 21 and above 268 (52.4)
 Mean (SD) 20.74 (1.43)
Gender
 Male 240 (47)
 Female 271 (53)
Field of study
 College of Medicine 248 (48.5)
 College of Dentistry 161 (31.5)
 College of Pharmacy 52 (10.2)
 Medical Laboratory College 50 (9.8)
Vaccinated against Hepatitis B
 Yes 217 (42.5)
 No 294 (57.5)
Doses of Hepatitis B vaccine received
 Not vaccinated 294 (57.5)
 One 41 (8)
 Two 80 (15.7)
 Three 87 (17)
 More than three 9 (1.8)
Reasons for not being vaccinated against Hepatitis B
 No vaccination program offered 182 (62)
 Low risk of Hepatitis B 26 (8.8)
 Not sure about the vaccination status 22 (7.5)
 Lack of knowledge 36 (12.2)
 Efficacy doubted 28 (9.5)

Assessment of knowledge related to Hepatitis B virus

Table 2 shows the knowledge of the participants on Hepatitis B. Most of the respondents agreed that Hepatitis B is caused by a virus (67.5% strongly agreed, 24.1% agreed) and can cause liver cancer (35.6% strongly agreed, 38.6% agreed). Regarding the knowledge of the participants on the mode of transmission, the majority of the students agreed that Hepatitis B can be transmitted by contaminated blood, body fluids, and unprotected sex (62.2% strongly agreed, 25.4% agreed). Similarly, most of the students disagreed that Hepatitis B can be transmitted by shaking hands, coughing/sneezing, and contaminated food/water (48.7% strongly disagreed, 27.2% disagreed) and 11% were neutral. About four-fifths of the participants agreed that healthcare workers are at increased risk of contracting Hepatitis B than the general population (50.9% strongly agreed, 28.2% agreed). In terms of knowledge on prevention, the majority of the students agreed that Hepatitis B can be prevented by vaccination, using gloves, and avoiding sharp needles/syringe injury (55.8% strongly agreed, 34.2% agreed).

Table 2. Assessment of knowledge related to Hepatitis B virus.

Variables Strongly Disagree n (%) Disagree n (%) Neutral n (%) Agree n (%) Strongly Agree n (%)
1. Hepatitis B is caused by a virus. 10 (2) 8 (1.6) 25 (4.9) 123 (24.1) 345 (67.5)
2. Hepatitis B can be transmitted by contaminated blood, body fluids, and unprotected sex. 11 (2.2) 22 (4.3) 30 (5.9) 130 (25.4) 318 (62.2)
3. Hepatitis B can be transmitted by shaking hands, Coughing/Sneezing, and contaminated food/water. 249 (48.7) 139 (27.2) 56 (11) 38 (7.4) 29 (5.7)
4. Hepatitis B can cause liver cancer. 13 (2.5) 23 (4.5) 96 (18.8) 197 (38.6) 182 (35.6)
5. Healthcare workers are at increased risk of getting Hepatitis B than the general population. 14 (2.7) 26 (5.1) 67 (13.1) 144 (28.2) 260 (50.9)
6. Hepatitis B can be prevented by vaccination, using gloves and avoiding sharp needles/syringe injury. 9 (1.8) 10 (2) 32 (6.3) 175 (34.2) 285 (55.8)

Assessment of attitude towards Hepatitis B virus

Table 3 shows the attitude of the participants toward Hepatitis B. Many of the students were neutral (n = 140, 27.4%) toward sitting with a Hepatitis B-infected person, however, 14.3% (n = 73) of the participants strongly agreed on feeling uncomfortable sitting with a Hepatitis B infected person and 14.5% (n = 74) strongly disagreed. Twenty-seven percent (n = 138) disagreed on shaking hands/hugging with an infected person, while 21.3% (n = 109) did not mind shaking hands/hugging with a Hepatitis B infected person and 25.4% (n = 130) were neutral. About 41.1% (n = 210) of students agreed that the Hepatitis B vaccine is safe and effective and 3.9% (n = 20) strongly disagreed. About two-thirds of the participants (66.7%, n = 341) strongly agreed that healthcare workers should receive Hepatitis B vaccination. About half of the respondents (52.6%, n = 269) strongly disagreed with not receiving Hepatitis B vaccination because they were not at risk.

Table 3. Assessment of attitude towards Hepatitis B virus.

Variables Strongly Disagree n (%) Disagree n (%) Neutral n (%) Agree n (%) Strongly Agree n (%)
1. I feel uncomfortable sitting with a Hepatitis B infected person. 74 (14.5) 93 (18.2) 140 (27.4) 131 (25.6) 73 (14.3)
2. I don’t mind shaking hands/hugging with a Hepatitis B infected person. 77 (15.1) 138 (27) 130 (25.4) 109 (21.3) 57 (11.2)
3. I believe the Hepatitis B vaccine is safe and effective. 20 (3.9) 19 (3.7) 76 (14.9) 210 (41.1) 186 (36.4)
4. I believe healthcare workers should receive Hepatitis B vaccination. 6 (1.2) 16 (3.1) 37 (7.2) 111 (21.7) 341 (66.7)
5. I don’t need Hepatitis B vaccination because I’m not at risk. 269 (52.6) 142 (27.8) 45 (8.8) 30 (5.9) 25 (4.9)

Assessment of practice towards Hepatitis B virus

Table 4 shows the practice of the respondents toward Hepatitis B. Among the participants, 38.2% (n = 195) asked/used a new blade for shaving/hair cutting. About sixty percent (n = 319) of the respondents asked for a new syringe before injection. About half of the students (50.3%, n = 257) ask for sterilized equipment for ear/nose piercing. While 42.5% (n = 217) stated that they would report for needle prick/ sharp injuries. Approximately one-third of students (n = 141) were neutral on attending Hepatitis B-related awareness campaigns and 13.9% (n = 71) strongly disagreed.

Table 4. Assessment of practice towards Hepatitis B virus.

Variables Strongly Disagree n (%) Disagree n (%) Neutral n (%) Agree n (%) Strongly Agree n (%)
1. I ask/use a new blade for shaving/hair cutting. 26 (5.1) 43 (8.4) 103 (20.2) 144 (28.2) 195 (38.2)
2. I ask for a new syringe before injection. 8 (1.6) 23 (4.5) 48 (9.4) 123 (24.1) 309 (60.5)
3. I ask for sterilized equipment for ear/nose piercing. 8 (1.6) 24 (4.7) 87 (17) 135 (26.4) 257 (50.3)
4. I will report for needle prick/ sharp injuries. 4 (0.8) 32 (6.3) 107 (20.9) 151 (29.5) 217 (42.5)
5. I attend Hepatitis B-related awareness campaigns. 71 (13.9) 68 (13.3) 141 (27.6) 139 (27.2) 92 (18)

Categorization of knowledge, attitude, and practice (KAP) score and its association with basic demographic characteristics and HBV vaccination status

The total median score of KAP was 65 as shown in Table 5. The median knowledge, attitude and practice score was 26,19,20, respectively Table 5. Table 6 shows the association between KAP score and basic demographic characteristics and HBV vaccination status including age, gender, the field of study (college), vaccination against the virus, doses of HBV vaccine, and reasons for not being vaccinated against HBV. We found a significant association between the KAP score and most of the variables. However, there was no significant association between gender (p-value = 0.093) and KAP score Table 6.

Table 5. Summation of knowledge, attitude, and practice score distribution.

Knowledge sum (n = 511) Attitude sum (n = 511) Practice sum (n = 511) Total Score (n = 511)
Mean 25.61 18.5 19.7 63.81
Median 26 19 20 65

Table 6. Association of KAP score with basic-demographic characteristics.

Variables KAP score Category *p-value
In-adequate (<65)n (%) Good (≥65) n (%)
Age 20 and below (n = 243) 142 (58.4) 101 (41.6) 0.00002
21 and above (n = 268) 106 (39.6) 162 (60.4)
Gender Male (n = 240) 126 (52.5) 114 (47.5) 0.093
Female (n = 271) 122 (45.02) 149 (54.98)
Field of study (College) Medicine (n = 248) 112 (45.16) 136 (54.84) 0.0002
Dentistry (n = 161) 73 (45.34) 88 (54.66)
Pharmacy (n = 52) 22 (42.31) 30 (57.69)
Medical Laboratory (n = 50) 41 (82) 9 (18)
Vaccinated against Hepatitis B Yes (n = 217) 85 (39.17) 132 (60.83) 0.0003
No (n = 294) 163 (55.44) 131 (44.56)
Doses of Hepatitis B vaccine received Not vaccinated (n = 294) 163 (55.4) 131 (44.56) 0.000428
One (n = 41) 19 (46.3) 22 (53.7)
Two (n = 80) 38 (47.5) 42 (52.5)
Three (n = 87) 26 (29.9) 61 (70.1)
More than three (n = 9) 2 (22.2) 7 (77.8)
Reasons for not being vaccinated against Hepatitis B No vaccination program offered (n = 182) 85 (46.7) 97 (53.3) 0.000851
Low risk of Hepatitis B (n = 26) 19 (73.1) 7 (26.9)
Not sure about the vaccination status (n = 22) 12 (54.5) 10 (45.5)
Lack of knowledge (n = 36) 24 (66.7) 12 (33.3)
Efficacy doubted (n = 28) 23 (82.1) 5 (17.9)

*P value is measured using Chi-Square, or Fisher’s exact test.

Discussion

Medical science students are at high risk of exposure to blood-borne infections such as Hepatitis B virus, as they provide direct patient care throughout the clerkship phase of the program, this places them in a similar risk category as healthcare professionals [13]. Therefore, it is imperative that all students should be vaccinated and acquire sufficient knowledge about the virus to minimize the risk of infection. In the Kurdistan Region of Iraq, there have been no studies to measure vaccination status as well as knowledge, attitude, and practice towards the Hepatitis B virus among medical sciences students, as far as authors’ knowledge are concerned. This study is designed to evaluate the vaccination status of medical sciences students and their KAP about the virus.

In our study, 42.5% of medical science students were vaccinated against Hepatitis B, which is higher than the findings of a study in Southwest Ethiopia, where only 25.7% of students were immunized [14]. However, our results are similar to a study from Pakistan, where 42.2% of students were vaccinated, and are quite lower than a study from Nigeria, where 47.7% of students reported that they had been vaccinated [15, 16]. Also, it is lower than research carried out in Uganda, where it was found that 66.8% of the participants had received vaccinations [17]. On the other hand, a more current study conducted in Pakistan found that 79% of their participants are vaccinated against Hepatitis B [18]. All in all, 18.8% of participants were fully vaccinated (3 doses or more), which is much greater than a study in Ethiopia, where just 2% of students were fully vaccinated [19]. In comparison to our findings, research in Nepal found that 37% of their students had completed all three doses of vaccination, which is greater than our study [12].

The primary reason for why 57.5% of the participants in our study were not vaccinated is due to having no vaccination programs (62%) followed by lack of knowledge (12.2%) and efficacy doubted (9.5%). Our results are in line with other studies conducted in Nepal and Nigeria, which found a lack of effective vaccination programs (43.2%) and a lack of opportunity (57.4%) as the main reasons for non-vaccination, respectively [16, 20]. These findings highlight the need for urgent implementation of vaccination programs for medical science students in the region. In Uganda, the high cost of vaccination (63.2%) was the most common obstacle for non-vaccination [17].

About 91.6% of the participants surveyed were aware that Hepatitis B is caused by a virus. Compared to a research study carried out in Nepal among medical and dental students, it was found that 93.6% of the students knew that Hepatitis B infection was caused by a virus [21]. The great majority of participants have a solid understanding of the mode of transmission, with 87.6% stating that transmission occurs through contaminated blood, fluid, and unprotected intercourse. These findings are consistent with those of Ethiopian and Nepalese studies [12, 19]. In the present study, 74.2% of participants agreed that the Hepatitis B virus can lead to liver cancer. This is comparable with research studies from Saudi Arabia, Nepal, and Ethiopia which revealed that 75.5%, 80.6%, and 81.3% of students agreed that Hepatitis B infection can cause liver cancer, respectively [12, 19, 22]. Ninety percent of respondents agreed that vaccination may prevent Hepatitis B infection. In this regard, comparable results were observed in studies carried out in Saudi Arabia, Nepal, and Ethiopia [12, 19, 22].

Around 39.9% and 42.1% of students showed a negative attitude towards sitting and shaking hands with a Hepatitis B infected person, respectively. Nepalese students demonstrated a more positive attitude [12]. In the present study, 77.5% of the students believed that the Hepatitis B vaccine was safe and efficient; somewhat higher results were obtained from studies conducted in Saudi Arabia, Nepal, and Ethiopia [12, 19, 22]. While compared to another study in Saudi Arabia, our findings are higher where only 63% of participants agreed that the vaccine is safe and effective [23]. A high enough percentage (88.4%) of our students agreed that healthcare workers should be vaccinated, which is similar to a study from Nepal [12]. According to our survey, 10.8% of participants believed that they were not at risk of contracting the Hepatitis B virus and that vaccination against Hepatitis B is not necessary. This figure nearly triples when compared to studies conducted in India and Nepal, whereas only 3.7% and 3.9% of their participants agreed with this statement, respectively [12, 24]. This concerned finding should be addressed because medical science students are part of the healthcare system and should be aware of the need for Hepatitis B vaccination since they are vulnerable to contracting the virus and spreading the infection in the community.

In our survey, 66.4%, 84.6%, and 76.7% of the students stated that they requested a new blade for shaving/hair cutting, new syringes to avoid infection, and sanitized equipment for piercing their ears and nose, respectively. Studies from India and Nepal reported better safety practices among their participants [12, 24]. These findings highlight the necessity of taking action that encourages students to adhere to infection control measures. 72% of the students agreed that they would report needle prick/sharp injuries. Our findings presented higher percentages than those indicated by studies in Saudi Arabia (68%), Nepal (64.6%), and Ethiopia (53.7%), where the participants will report needle injuries [12, 19, 22]. Also, similar to the findings of a study in Nepal (i.e., 44.2%), a percentage of 45.2% of the study participants said that they have attended Hepatitis B related awareness programs [12].

In this study, we found that the female gender is associated with better overall KAP scores when compared to males. These findings are similarly reported in the previous studies from Pakistan and Nepal [12, 18]. However, a study from Malaysia revealed no association between gender and knowledge about Hepatitis B [25]. Students who were vaccinated showed a better KAP score than those who were not. A similar result was reported by a Nepalese study [12].

Limitations and strengths of the study

The main limitation of this research is that vaccination status was self-reported and not confirmed by the measurement of the anti-Hepatitis B surface antibody (HBsAb) titer of the students. Therefore, recall bias and erroneous information might have affected the findings of the research. Since the study was conducted only in Duhok province in the Kurdistan Region of Iraq, the results cannot be generalized to all medical science colleges in the region, but they will undoubtedly serve as a background for future studies in the region. Finally, the nature of the study was cross-sectional, and it did not measure the cause-and-effect relationship. Despite the limitations, the study was strengthened by the large sample size used to measure individuals’ vaccination status and KAP against the Hepatitis B virus, which minimized the likelihood of bias.

Conclusions

In the present study, more than half of the participants were not vaccinated against Hepatitis B despite it being a preventable disease, and only one-fifth of students were fully vaccinated. The lack of vaccination programs was the main reason for the study participants not to be vaccinated against Hepatitis B. Moreover, about half of the participants had good knowledge, attitude, and practice (KAP) regarding Hepatitis B, and students who were vaccinated displayed a better KAP score than those who were non-vaccinated. The administrators of the medical sciences college should prioritize the implementation of a vaccination program.

Recommendations

Since all medical science students are susceptible to Hepatitis B infection as they are exposed to the infected blood and blood products in their professional career, therefore, all students should be vaccinated against the Hepatitis B virus upon enrollment at the college. The COVID-19 pandemic has had a significant impact on the region’s healthcare system including medical education [2628]. This has negatively impacted and postponed many infection prevention programs in the Kurdistan Region [29]. This might be linked to low vaccination coverage in our study. According to Khan et al., a pretest, followed by a lecture and demonstration of standard infection control measures and precautions, and concluded with a posttest, has the potential to enhance knowledge and bring about attitudinal changes [30]. Therefore, we recommend the implementation of a vaccination program and the provision of training on infection prevention guidelines through lectures and workshops to increase students’ knowledge, attitude, and practice toward Hepatitis B.

Supporting information

S1 Dataset

(XLSX)

Acknowledgments

We would like to express sincere gratitude to all students who took part in this study.

Data Availability

All data is available within the paper and Supporting information file without any restriction.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582–92. doi: 10.1016/S0140-6736(09)60207-5 . [DOI] [PubMed] [Google Scholar]
  • 2.Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, et al. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Gastroenterology & Hepatology. 2022;7(9):796–829. doi: 10.1016/S2468-1253(22)00124-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63. Epub 20140618. doi: 10.1016/S0140-6736(14)60220-8 . [DOI] [PubMed] [Google Scholar]
  • 4.Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med. 2004;351(27):2832–8. doi: 10.1056/NEJMcp041507 . [DOI] [PubMed] [Google Scholar]
  • 5.Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35(11):1368–75. Epub 20021112. doi: 10.1086/344271 . [DOI] [PubMed] [Google Scholar]
  • 6.Lu T, Seto WK, Zhu RX, Lai CL, Yuen MF. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol. 2013;19(47):8887–94. doi: 10.3748/wjg.v19.i47.8887 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Singhal V, Bora D, Singh S. Hepatitis B in health care workers: Indian scenario. J Lab Physicians. 2009;1(2):41–8. doi: 10.4103/0974-2727.59697 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Abdullah RA, Badal R, Hussein NR, Jaafar S, Yaqoob ES, Salih RS, et al. Hepatitis B Knowledge Among Healthy Volunteers in Duhok City, Kurdistan Region, Iraq. 2017;4(4):e14976. Epub 2017-06-01. doi: 10.5812/iji.14976 [DOI] [Google Scholar]
  • 9.Rasheed Hussein N, Mohamad Haj S, Amin Almizori L, Ahmed Taha A. The Prevalence of Hepatitis B and C Viruses Among Blood Donors Attending Blood Bank in Duhok, Kurdistan Region, Iraq. 2017;4(1):e39008. Epub 2016-08-01. doi: 10.17795/iji-39008 [DOI] [Google Scholar]
  • 10.Khalid FK, Rasheed NA, Hussein NR, Naqid IA. A study of HBV infection and its risk factors in pregnant women in Zakho city, Iraq. PLOS ONE. 2022;17(8):e0273362. doi: 10.1371/journal.pone.0273362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hussein NR, Musa DH, Hawezy DJ, Ahmed FMR, Khalid FK, Naqid IA, et al. A study on the prevalence and the risk factors of hepatitis B virus infection in Kurdistan Region, Iraq: A multicenter study: Prevalence and the risk factors of HBV. Journal of Contemporary Medical Sciences. 2021;7(5). doi: 10.22317/jcms.v7i5.1037 [DOI] [Google Scholar]
  • 12.Shrestha DB, Khadka M, Khadka M, Subedi P, Pokharel S, Thapa BB. Hepatitis B vaccination status and knowledge, attitude, and practice regarding Hepatitis B among preclinical medical students of a medical college in Nepal. PLoS One. 2020;15(11):e0242658. Epub 20201123. doi: 10.1371/journal.pone.0242658 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ali AS, Hussein NA, Elmi EOH, Ismail AM, Abdi MM. Hepatitis B vaccination coverage and associated factors among medical students: a cross-sectional study in Bosaso, Somalia, 2021. BMC Public Health. 2023;23(1). doi: 10.1186/s12889-023-15992-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Haile K, Timerga A, Mose A, Mekonnen Z. Hepatitis B vaccination status and associated factors among students of medicine and health sciences in Wolkite University, Southwest Ethiopia: A cross-sectional study. PLOS ONE. 2021;16(9):e0257621. doi: 10.1371/journal.pone.0257621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nasir K, Khan KA, Kadri WM, Salim S, Tufail K, Sheikh HZ, et al. Hepatitis B vaccination among health care workers and students of a medical college. J Pak Med Assoc. 2000;50(7):239–43. . [PubMed] [Google Scholar]
  • 16.Okeke EN, Ladep NG, Agaba EI, Malu AO. Hepatitis B vaccination status and needle stick injuries among medical students in a Nigerian university. Niger J Med. 2008;17(3):330–2. doi: 10.4314/njm.v17i3.37404 . [DOI] [PubMed] [Google Scholar]
  • 17.Wibabara Y, Banura C, Kalyango J, Karamagi C, Kityamuwesi A, Amia WC, et al. Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences. PLOS ONE. 2019;14(4):e0214732. doi: 10.1371/journal.pone.0214732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Khan N, Ahmed SM, Khalid MM, Siddiqui SH, Merchant AA. Effect of gender and age on the knowledge, attitude and practice regarding hepatitis B and C and vaccination status of hepatitis B among medical students of Karachi, Pakistan. J Pak Med Assoc. 2010;60(6):450–5. . [PubMed] [Google Scholar]
  • 19.Abdela A, Woldu B, Haile K, Mathewos B, Deressa T. Assessment of knowledge, attitudes and practices toward prevention of hepatitis B virus infection among students of medicine and health sciences in Northwest Ethiopia. BMC Research Notes. 2016;9(1):410. doi: 10.1186/s13104-016-2216-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bhattarai S, Kc S, Pradhan PMS, Lama S, Rijal S. Hepatitis B vaccination status and Needle-stick and Sharps-related Injuries among medical school students in Nepal: a cross-sectional study. BMC Research Notes. 2014;7(1):774. doi: 10.1186/1756-0500-7-774 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Shah DK, Jha RK, Ansari S, Sah P, Dhungana GP, Basnet S. Knowledge and awareness regarding hepatitis B among preclinical medical and dental students of Chitwan Medical College Nepal: a questionnaire-based study. Int J Med Sci Public Health. 2016;5(11):2316–21. [Google Scholar]
  • 22.Alhowaish MA, Alhowaish JA, Alanazi YH, Alshammari MM, Alshammari MS, Alshamari NG, et al. Knowledge, attitudes and practices toward prevention of hepatitis B virus infection among medical students at Northern Border University, Arar, Kingdom of Saudi Arabia. Electron Physician. 2017;9(9):5388–94. Epub 20170925. doi: 10.19082/5388 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Al-Hazmi A. Knowledge, attitudes, and practice of medical students regarding occupational risks of hepatitis B virus in college of medicine, aljouf university. Ann Med Health Sci Res. 2015;5(1):13–9. doi: 10.4103/2141-9248.149765 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Rathi A, Kumar V, Majhi J, Jain S, Lal P, Singh S. Assessment of knowledge, attitude, and practices toward prevention of hepatitis B infection among medical students in a high-risk setting of a newly established medical institution. J Lab Physicians. 2018;10(4):374–9. doi: 10.4103/JLP.JLP_93_18 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ahmad A, Munn Sann L, Abdul Rahman H. Factors associated with knowledge, attitude and practice related to hepatitis B and C among international students of Universiti Putra Malaysia. BMC Public Health. 2016;16:611. Epub 20160721. doi: 10.1186/s12889-016-3188-5 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hussein N. The Impact of COVID-19 Pandemic on the Elimination of Viral Hepatitis in Duhok City, Kurdistan Region of Iraq. 2020;20(5):e104643. Epub 2020-05-20. doi: 10.5812/hepatmon.104643 [DOI] [Google Scholar]
  • 27.Hussein NR, Abdullah AS, Majed HS, Naqid IA, Abdi BA, Rashad BH, et al. Recurrence Rate of Hepatitis C Virus After Achieving a Sustained Virologic Response in Kurdistan Region, Iraq. Avicenna J Clin Microbiol Infect. 2020;7(3):72–4. doi: 10.34172/ajcmi.2020.16 [DOI] [Google Scholar]
  • 28.Mosa AA, Ibrahim SV, Naqid IA, Hawezy DJ, Al-Jaf SMA, Hussein NR. The Impact of SARS-CoV-2 Pandemic on Medical Students: Knowledge, Attitudes, and Practices towards E-Learning: An Online Cross-Sectional Study in the Kurdistan Region, Iraq. Galician Medical Journal. 2023;30(1):E202314. doi: 10.21802/gmj.2023.1.4 [DOI] [Google Scholar]
  • 29.Daniel S, Mohammed AS, Ibrahim N, Hussein NR, Balatay AA, Naqid IA, et al. Human papillomavirus (HPV) genotype prevalence and impact of COVID-19 on the HPV prevention program in Duhok city. Dialogues Health. 2022;1:100055. Epub 20221003. doi: 10.1016/j.dialog.2022.100055 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Khan N, Asghar S, Ahmed H, Khan MA. Knowledge, attitudes, and practices about hepatitis B among medical and dental students of Karachi. Ibnosina Journal of Medicine and Biomedical Sciences. 2021;13(1):20. doi: 10.4103/ijmbs.ijmbs_140_20 [DOI] [Google Scholar]

Decision Letter 0

Mohamed Lounis

6 Sep 2023

PONE-D-23-22175Hepatitis B Vaccination Status and Knowledge, Attitude, and Practice towards Hepatitis B virus among Medical Sciences Students: A Cross-Sectional StudyPLOS ONE

Dear Dr. Naqid,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:- The manuscript needs an extensive proof-readingfor English language.

- In the abstract, you should provide what was the scale used. Giving just a score of 20 or 26 has no sense.

- Improve the quality of your tables.

- You should provide the references used to categorize the scores. In fact, considering those who have a score of 64 with those having an evantual score  of 10 is ambigous. 

- Figure 1 is not necessary.

- Table 1 may be "demographics and HBV vaccination status. 

 - In table 6 you can include the other factors that could be associated with tKAP.mAP. ==============================

Please submit your revised manuscript by Oct 21 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohamed Lounis

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript needs to be revised by a native English speaker as there are many typographical errors and grammatical mistakes.

Introduction is good but need to improve the quality of writing (English proofreading).

Why is 2010 Global Burden of Disease study being quoted when there are far more recent reports from the GBD.

Too much detail about mode of transmission in first paragraph. Can be reduced. The main mode of transmission to be concerned with is that of needle stick injuries…etc. The rest can be summarized.

Methodology is sound but give information on if the study was piloted and what language the questionnaire was in. Reference 12 (Nepal study) that the study was based on was in English I presume, so if there was a translated questionnaire, was anything done to ensure validity and reliability of the translated questionnaire?

Discussion focuses too much on comparison with the Nepal study and a Saudi one. Was a thorough literature search conducted to gain more of a worldwide view on the matter?

The study did not explore whether or not students would get vaccinated if it were a prerequisite by their college for clinical training, as that would be a strong recommendation if the results of this question yielded a high response.

Reviewer #2: Revise the manuscript according to the suggestions and recommendations as indicated in the revised manuscript. Many grammatical mistakes. It is better to show the article to a English consultant to improve the language.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr. Nazeer Khan

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-23-22175_reviewer.docx

PLoS One. 2023 Nov 6;18(11):e0293822. doi: 10.1371/journal.pone.0293822.r002

Author response to Decision Letter 0


18 Sep 2023

The Response to Reviewers Letter

PLOS ONE JOURNAL

Dear Editor

Thank you for your kind comments, we found the editorial board and reviewers' comments on our submitted manuscript draft to be very valuable. We believe that our paper is significantly strengthened after responding to the comments.

We have carefully reviewed the comments and have modified the manuscript accordingly. The revised points are highlighted in RED in the revised manuscript file.

Response to “ACADEMIC EDITOR” comments

1. The manuscript needs extensive proof-reading for English language

- The manuscript has been revised for typo-grammatical errors by an English language editor

2. In the abstract, you should provide what was the scale used. Giving just a score of 20 or 26 has no sense

- Five-point Likert scale has been added to the abstract in the materials and methods section.

3. Improve the quality of your tables.

- Done

4. You should provide the references used to categorize the scores. In fact, considering those who have a score of 64 with those having an eventual score of 10 is ambiguous.

-Addressed as appropriate in Materials and Methods section

5. Figure 1 is not necessary.

-Removed

6. Table 1 may be "demographics and HBV vaccination status.

-Done

7. In table 6 you can include the other factors that could be associated with KAP

-Done

All comments provided by the editorial board are adequately responded to.

Response to “REVIEWERS” Comments

• Reviewer #1

1. The manuscript needs to be revised by a native English speaker as there are many typographical errors and grammatical mistakes.

- The manuscript has been revised for typo-grammatical errors by an English language editor

2. Comments on introduction

-All comments have been addressed

3. Why is 2010 Global Burden of Disease study being quoted when there are far more recent reports from the GBD.

-Reference has been updated

4. Methodology is sound but give information on if the study was piloted and what language the questionnaire was in. Reference 12 (Nepal study) that the study was based on was in English I presume, so if there was a translated questionnaire, was anything done to ensure validity and reliability of the translated questionnaire?

-Medical sciences colleges in the Kurdistan region of Iraq are in English language. So, all the students are able to answer the questionnaire in English language. Therefore, it did not require translation of the questionnaire.

5. Discussion focuses too much on comparison with the Nepal study and a Saudi one. Was a thorough literature search conducted to gain more of a worldwide view on the matter.

– The study was compared to neighboring countries and other developing countries.

• Reviewer #2

-All the comments provided by reviewer #2 in the reviewed Microsoft Word file are addressed as appropriate.

Modification to References

- Reference number [2] has been updated as appropriate.

- Reference number [12] has been added to last sentence of Material and Methods section/Study tool subheading.

Note: All data are available within the manuscript and supporting information without any restriction

We hope that the manuscript is now suitable for your journal, looking forward to hearing from you.

Sincerely,

Asst. Prof. Dr Ibrahim A. Naqid

Department of Biomedical Sciences,

College of Medicine, University of Zakho

Zakho International Road, Duhok, Kurdistan Region-Iraq

P.O. Box12

Email: ibrahim.naqid@uoz.edu.krd

Tel:. 009647504737593

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Mohamed Lounis

3 Oct 2023

PONE-D-23-22175R1Hepatitis B Vaccination Status and Knowledge, Attitude, and Practice towards Hepatitis B virus among Medical Sciences Students: A Cross-Sectional StudyPLOS ONE

Dear Dr. Naqid,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:You should take into consideration all the comments of the Editor ad the reviewers.You should take into consideration the comments of the atached fie.==============================

Please submit your revised manuscript by Nov 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohamed Lounis

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Author has addressed most of the comments, but did not address few of them, and did not write why those comments are unattended. Please see my previous comments in the attachemnt.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Dr. Nazeer Khan

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-23-22175_reviewer.docx

PLoS One. 2023 Nov 6;18(11):e0293822. doi: 10.1371/journal.pone.0293822.r004

Author response to Decision Letter 1


11 Oct 2023

The Response to Reviewers Letter

PLOS ONE JOURNAL

Dear Editor

Thank you for your kind comments, we found the remaining unaddressed reviewer’s comments on our submitted manuscript draft to be very valuable. We believe that our paper is further strengthened after responding to the remaining comments.

We have carefully reviewed the comments and have modified the manuscript accordingly. The revised points are highlighted in BLUE in the revised manuscript file.

Response to remaining “REVIEWERS” Comments

• Reviewer #2

1. Materials and Methodology: Year of study of the students?

- Unfortunately, has not been included in our questionnaire.

2. Results: Dividing the favorable and non-favorable at median?

-It is cited in the methodology that we followed reference 12.

3. Discussion: Reference that supports the below statement “Medical students are at comparable risk of getting hepatitis B compared to Health care workers”

-A new reference has been added.

4. Discussion: Comparing to other Pakistan study, reference 23 in the old file and reference 18 in the new file

-Done.

5. Discussion: Does Nepali private hospitals offer vaccination services with some cost. Then cost could be one of the barriers for not vaccination.

-Private hospitals in Nepal provide Hepatitis B vaccination with some cost, but according to what’s available in the literature, we found that cost is not a major barrier to non-vaccination among Nepalese students. For example, in reference 12 only 2 students (1.1%) stated high cost of vaccination as a barrier.

6. A study has been added to support our recommendations

Modification to References

- Two references have been added newly, reference number [13] and [30].

- Reference number [23] has been changed to reference number [18].

We hope that the manuscript is now suitable for your journal, looking forward to hearing from you.

Sincerely,

Asst. Prof. Dr Ibrahim A. Naqid

Department of Biomedical Sciences,

College of Medicine, University of Zakho

Zakho International Road, Duhok, Kurdistan Region-Iraq

P.O. Box12

Email: Ibrahim.naqid@uoz.edu.krd

Tel:. 009647504737593

Attachment

Submitted filename: Response to Reviewers R2.docx

Decision Letter 2

Mohamed Lounis

18 Oct 2023

PONE-D-23-22175R2Hepatitis B Vaccination Status and Knowledge, Attitude, and Practice towards Hepatitis B virus among Medical Sciences Students: A Cross-Sectional StudyPLOS ONE

Dear Dr. Naqid,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohamed Lounis

Academic Editor

PLOS ONE

Additional Editor Comments:

In your tables Change "No." to "n".

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: You revised the manuscript according to the suggestions. However, few more minor ones were left without giving any justification.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Dr. Nazeer Khan

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 3

Mohamed Lounis

20 Oct 2023

Hepatitis B Vaccination Status and Knowledge, Attitude, and Practice towards Hepatitis B virus among Medical Sciences Students: A Cross-Sectional Study

PONE-D-23-22175R3

Dear Dr. Naqid,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mohamed Lounis

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Mohamed Lounis

27 Oct 2023

PONE-D-23-22175R3

Hepatitis B Vaccination Status and Knowledge, Attitude, and Practice towards Hepatitis B Virus among Medical Sciences Students: A Cross-Sectional Study

Dear Dr. Naqid:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mohamed Lounis

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Dataset

    (XLSX)

    Attachment

    Submitted filename: PONE-D-23-22175_reviewer.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: PONE-D-23-22175_reviewer.docx

    Attachment

    Submitted filename: Response to Reviewers R2.docx

    Attachment

    Submitted filename: Response to Reviewers R3.docx

    Data Availability Statement

    All data is available within the paper and Supporting information file without any restriction.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES